These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31118157)

  • 1. Total and differential white blood cell counts, inflammatory markers, adipokines, and incident metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
    Kelly CW; McEvoy JP; Miller BJ
    Schizophr Res; 2019 Jul; 209():193-197. PubMed ID: 31118157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total and differential white blood cell counts, inflammatory markers, adipokines, and the metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
    Mori N; McEvoy JP; Miller BJ
    Schizophr Res; 2015 Dec; 169(1-3):30-35. PubMed ID: 26475215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of C-reactive protein and IL-6 among the antipsychotic medicating schizophrenia patients of Siliguri, West Bengal, India.
    Gurung J; Chamlagai D; Bera NK; Chaudhuri TK; Singh B
    Nord J Psychiatry; 2018 May; 72(4):311-317. PubMed ID: 29464976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine.
    Klemettilä JP; Kampman O; Seppälä N; Viikki M; Hämäläinen M; Moilanen E; Leinonen E
    Psychiatry Res; 2014 Aug; 218(3):277-83. PubMed ID: 24837425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses.
    Miller BJ; Mellor A; Buckley P
    Brain Behav Immun; 2013 Jul; 31():82-9. PubMed ID: 22982547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole-induced adverse metabolic alterations in polyI:C neurodevelopmental model of schizophrenia in rats.
    Horska K; Ruda-Kucerova J; Drazanova E; Karpisek M; Demlova R; Kasparek T; Kotolova H
    Neuropharmacology; 2017 Sep; 123():148-158. PubMed ID: 28595931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of adipokines with metabolic disorders in patients with schizophrenia: Results of comparative study with mental healthy cohort.
    Tanyanskiy DA; Martynikhin IA; Rotar OP; Konradi AO; Sokolian NA; Neznanov NG; Denisenko AD
    Diabetes Metab Syndr; 2015; 9(3):163-7. PubMed ID: 25952038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
    Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of the HTR2C, leptin and adiponectin genes and serum marker analyses in clozapine treated long-term patients with schizophrenia.
    Klemettilä JP; Kampman O; Seppälä N; Viikki M; Hämäläinen M; Moilanen E; Mononen N; Lehtimäki T; Leinonen E
    Eur Psychiatry; 2015 Feb; 30(2):296-302. PubMed ID: 25284335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overweight, hypertension and cardiovascular disease: focus on adipocytokines, insulin, weight changes and natriuretic peptides.
    Seven E
    Dan Med J; 2015 Nov; 62(11):B5163. PubMed ID: 26522487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
    Miller BJ; Buckley PF; McEvoy JP
    Schizophr Res; 2018 May; 195():275-282. PubMed ID: 28843438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of antipsychotic drugs on nonspecific inflammation markers in the first episode of schizophrenia.
    Stefanović V; Mihajlović G; Nenadović M; Dejanović SD; Borovcanin M; Trajković G
    Vojnosanit Pregl; 2015 Dec; 72(12):1085-92. PubMed ID: 26898032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Irisin, Adiponectin and Leptin Levels in Patients with Schizophrenia.
    Erzin G; Topcuoglu C; Kotan VO; Bayram S; Fountoulakis K
    Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):163-169. PubMed ID: 29219062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin.
    Jin H; Meyer JM; Mudaliar S; Jeste DV
    Schizophr Res; 2008 Mar; 100(1-3):70-85. PubMed ID: 18206351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin D supplementation on selected inflammatory biomarkers in older adults: a secondary analysis of data from a randomised, placebo-controlled trial.
    Waterhouse M; Tran B; Ebeling PR; English DR; Lucas RM; Venn AJ; Webb PM; Whiteman DC; Neale RE
    Br J Nutr; 2015 Sep; 114(5):693-9. PubMed ID: 26206095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses.
    Miller BJ; Kandhal P; Rapaport MH; Mellor A; Buckley P
    Brain Behav Immun; 2015 Mar; 45():28-35. PubMed ID: 25542737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome.
    Beumer W; Drexhage RC; De Wit H; Versnel MA; Drexhage HA; Cohen D
    Psychoneuroendocrinology; 2012 Dec; 37(12):1901-11. PubMed ID: 22541717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between serum adiponectin levels, cardiometabolic indices and metabolic syndrome in schizophrenia.
    Tay YH; Lee J
    Asian J Psychiatr; 2019 Jun; 43():1-6. PubMed ID: 31059867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
    Meyer JM; McEvoy JP; Davis VG; Goff DC; Nasrallah HA; Davis SM; Hsiao JK; Swartz MS; Stroup TS; Lieberman JA
    Biol Psychiatry; 2009 Dec; 66(11):1013-22. PubMed ID: 19640511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation markers are associated with metabolic syndrome and ventricular arrhythmia in patients with coronary artery disease.
    Safranow K; Dziedziejko V; Rzeuski R; Czyżycka E; Bukowska H; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
    Postepy Hig Med Dosw (Online); 2016 Feb; 70():56-66. PubMed ID: 26864064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.